文献速递艾滋病与性传播感染

全球HIV-1临床分离株对fostemsavir的敏感性:基于PhenoSense Entry检测的分析

Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense® Entry assay.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

该研究采用Monogram Biosciences PhenoSense® Entry检测法,分析了1337个涵盖20种HIV-1亚型的包膜蛋白对temsavir的敏感性。结果显示大多数亚型病毒对temsavir高度敏感(IC50<10 nM),但CRF01_AE亚型全部5个分离株IC50>100 nM;在607个有嗜性数据的分离株中,temsavir的几何平均IC50在CCR5、CXCR4及双嗜性包膜间相似,表明敏感性不依赖嗜性。

要点

  • 大多数HIV-1亚型临床分离株对temsavir高度敏感,IC50多<10 nM。
  • CRF01_AE亚型分离株对temsavir敏感性降低,5株IC50均>100 nM。
  • temsavir敏感性在CCR5、CXCR4及双嗜性病毒间相似,不依赖嗜性。

核心结论

  • 来自大多数亚型的HIV-1病毒对temsavir高度敏感,且temsavir敏感性独立于病毒嗜性。

研究设计与样本

  • 利用Monogram Biosciences PhenoSense® Entry检测法,对开发项目中的所有临床分离株进行分析,共检测1337个涵盖20种HIV-1亚型的包膜蛋白对temsavir的敏感性。

主要发现

  • 所有亚型内均观察到敏感性变异,但大多数病毒IC50<10 nM。
  • CRF01_AE亚型的全部5个分离株IC50>100 nM。
  • 在607个有嗜性数据的分离株中,CCR5、CXCR4和双混合嗜性包膜的temsavir几何平均IC50值非常相似。

关键数值与推荐

  • 大多数病毒IC50<10 nM;CRF01_AE分离株IC50>100 nM;亚型B有881株、亚型C有156株,仅7个亚型出现超过5次。

临床怎么用

  • 提示temsavir对多数HIV-1亚型具有强效抑制活性,临床用药时需注意CRF01_AE亚型可能敏感性降低。

局限性

  • 仅7个亚型分离株数超过5次,部分亚型代表性不足;嗜性数据仅覆盖607株。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fostemsavir is a prodrug of a first-in-class HIV-1 attachment inhibitor, temsavir, that binds to gp120 and blocks attachment to the host-cell CD4 receptor, preventing entry and infection of the target cell. Previous studies using a limited number of clinical isolates showed that there was intrinsic variability in their susceptibility to temsavir. OBJECTIVES: Here, an analysis was performed using all clinical isolates analysed in the Monogram Biosciences PhenoSense® Entry assay as part of the development programme. METHODS: In total, 1337 individual envelopes encompassing 20 different HIV-1 subtypes were examined for their susceptibility to temsavir. However, only seven subtypes (B, C, F1, A, [B, F1], BF and A1) were present more than five times, with subtype B (881 isolates) and subtype C (156 isolates) having the largest numbers. RESULTS: As expected, variability in susceptibility was observed within all subtypes. However, for the great majority of these viruses, temsavir was highly potent, with most viruses exhibiting IC50s <10 nM. One exception was CRF01_AE viruses, where all five isolates exhibited IC50s >100 nM. For the 607 isolates where tropism data were available, geometric mean temsavir IC50 values were remarkably similar for CCR5-, CXCR4- and dual mixed-tropic envelopes from infected individuals. CONCLUSIONS: These data show that HIV-1 viruses from most subtypes are highly susceptible to temsavir and that temsavir susceptibility is independent of tropism.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Gartland M, Zhou N, Stewart E, et al. Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense® Entry assay. J Antimicrob Chemother. 2021. PMID: 33241285. doi:10.1093/jac/dkaa474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。